SEC Form 4 · accession 0001140361-15-043921
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven M. Nardi
Officer — VP of Manufacturing
Period of report
Dec 4, 2015
Accepted (ET)
Dec 8, 2015 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 4, 2015 | A | 2,187 | $1.48 | A | 3,187 | D | |
| Common Stock | Dec 4, 2015 | A | 1,563 | $1.48 | A | 4,750 | D | |
| Common StockF1 | Dec 4, 2015 | S | 3,750 | $31.1208 | D | 1,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.48 | Dec 4, 2015 | M | 2,187 | D | — | Dec 11, 2023 | Common Stock | 8,750 | 6,563 | D |
| Stock Option (Right to Buy)F3 | $1.48 | Dec 4, 2015 | M | 1,563 | D | — | Dec 29, 2023 | Common Stock | 8,750 | 7,187 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $31.00 to $31.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This option, representing a right to purchase a total of 8,750 shares, was granted on 12/13/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.
- F3This option, representing a right to purchase a total of 8,750 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.